Heterotopic vascular calcification is a common complication of maintenance hemodialysis (MHD) patients. Galectin 3 (Gal‐3) has been reported to be associated with cardiovascular calcification. The current study aims to explore… Click to show full abstract
Heterotopic vascular calcification is a common complication of maintenance hemodialysis (MHD) patients. Galectin 3 (Gal‐3) has been reported to be associated with cardiovascular calcification. The current study aims to explore the potential predictive value of serum Gal‐3 for severe abdominal aortic calcification (AAC) and AAC progression in MHD patients.
               
Click one of the above tabs to view related content.